Oral fluorouracil vs vinorelbine plus cisplatin as adjuvant chemotherapy for stage II‐IIIA non‐small cell lung cancer: Propensity score‐matched and instrumental variable analyses

BACKGROUND: Adjuvant chemotherapy with vinorelbine plus cisplatin (VNR/CDDP) is a standard regimen for treatment of postoperative stage II‐IIIA non‐small cell lung cancer (NSCLC). However, oral fluorouracil offers a feasible alternative adjuvant chemotherapeutic regimen. We compared the prognoses of...

Descripción completa

Detalles Bibliográficos
Autores principales: Urushiyama, Hirokazu, Jo, Taisuke, Yasunaga, Hideo, Michihata, Nobuaki, Matsui, Hiroki, Hasegawa, Wakae, Takeshima, Hideyuki, Sakamoto, Yukiyo, Hiraishi, Yoshihisa, Mitani, Akihisa, Fushimi, Kiyohide, Nagase, Takahide, Yamauchi, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198210/
https://www.ncbi.nlm.nih.gov/pubmed/30151905
http://dx.doi.org/10.1002/cam4.1725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198210/
https://www.ncbi.nlm.nih.gov/pubmed/30151905
http://dx.doi.org/10.1002/cam4.1725

Ejemplares similares